{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:22:42Z","timestamp":1793956962686,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LHDMY25H030002"],"award-info":[{"award-number":["LHDMY25H030002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cbi.2025.111748","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:19:46Z","timestamp":1758125986000},"page":"111748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["HTR1D regulates the PI3K\/Akt signaling pathway to impact glioblastoma development and resistance to temozolomide"],"prefix":"10.1016","volume":"421","author":[{"given":"Huanqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5188-3848","authenticated-orcid":false,"given":"Ziyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-478X","authenticated-orcid":false,"given":"Yangling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2025.111748_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pmr.2016.08.005","article-title":"Brain tumors and metastases","volume":"28","author":"Vargo","year":"2017","journal-title":"Phys. Med. Rehabil. Clin"},{"key":"10.1016\/j.cbi.2025.111748_bib2","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cbi.2025.111748_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3390\/ph7070797","article-title":"The medicinal chemistry of imidazotetrazine prodrugs","volume":"7","author":"Moody","year":"2014","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2025.111748_bib4","first-page":"401","article-title":"Vortioxetine exhibits anti-glioblastoma activity via the PI3K-Akt signaling pathway, Iran","volume":"28","author":"Zhang","year":"2025","journal-title":"J. Basic Med. Sci."},{"key":"10.1016\/j.cbi.2025.111748_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1017\/S1461145711001027","article-title":"A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder","volume":"15","author":"Alvarez","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.cbi.2025.111748_bib6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1517\/14740338.2015.1046836","article-title":"Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder","volume":"14","author":"Sukhni","year":"2015","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.cbi.2025.111748_bib7","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.7150\/thno.55986","article-title":"Role of serotonin receptor signaling in cancer cells and anti-tumor immunity","volume":"11","author":"Karmakar","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2025.111748_bib8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.bcp.2010.06.046","article-title":"Glial cell line-derived neurotrophic factor induces cell migration and matrix metalloproteinase-13 expression in glioma cells","volume":"80","author":"Lu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111748_bib9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3390\/cells11081281","article-title":"Expression of the human serotonin 5-HT7 receptor rescues phenotype profile and restores dysregulated biomarkers in a Drosophila melanogaster glioma model","volume":"11","author":"Courant","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2025.111748_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/genes15121541","article-title":"5-Hydroxytryptamine G-Protein-Coupled receptor family genes: key players in cancer prognosis, immune regulation, and therapeutic response","volume":"15","author":"Liu","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.cbi.2025.111748_bib11","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.7150\/ijbs.70546","article-title":"HTR1D functions as a key target of HOXA10-AS\/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway","volume":"18","author":"Wu","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2025.111748_bib12","first-page":"2448","article-title":"HTR1D, TIMP1, SERPINE1, MMP3 and CNR2 affect the survival of patients with colon adenocarcinoma","volume":"18","author":"Zeng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.cbi.2025.111748_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.bbrc.2022.06.088","article-title":"Knockdown and inhibition of hydroxytryptamine receptor 1D suppress proliferation and migration of gastric cancer cells","volume":"620","author":"Jin","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2025.111748_bib14","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12906-017-2006-7","article-title":"Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt\/\u03b2-catenin signaling in colorectal cancer cells","volume":"17","author":"Pan","year":"2017","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.cbi.2025.111748_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12885-025-13575-5","article-title":"HTR1D regulates the PI3K\/Akt signaling pathway to impact hepatocellular carcinoma development and resistance to sorafenib","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cbi.2025.111748_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.phrs.2024.107128","article-title":"Vanillic acid restores homeostasis of intestinal epithelium in colitis through inhibiting CA9\/STIM1-mediated ferroptosis","volume":"202","author":"Ni","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2025.111748_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155759","article-title":"Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2025.111748_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114798","article-title":"Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: principles and application","volume":"194","author":"Ren","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111748_bib19","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/nar\/gkz382","article-title":"SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules","volume":"47","author":"Daina","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2025.111748_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ncb0405-336","article-title":"Cell polarization mechanisms during directed cell migration","volume":"7","author":"Huttenlocher","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2025.111748_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2025.111748_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2025.111748_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/neuonc\/noz232","article-title":"A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)","volume":"22","author":"Cloughesy","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.cbi.2025.111748_bib24","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.6004\/jnccn.2020.0052","article-title":"Central nervous system cancers, Version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Nabors","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.cbi.2025.111748_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(18)30675-2","article-title":"Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial","volume":"20","author":"Lombardi","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cbi.2025.111748_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101993","article-title":"Evolving role of regorafenib for the treatment of advanced cancers","volume":"86","author":"Grothey","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.cbi.2025.111748_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3892\/ijo.2022.5359","article-title":"Signaling pathways and therapeutic approaches in glioblastoma multiforme","volume":"60","author":"Khabibov","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2025.111748_bib28","doi-asserted-by":"crossref","first-page":"20095","DOI":"10.18632\/aging.103593","article-title":"Depressive and anxiety disorders worsen the prognosis of glioblastoma","volume":"12","author":"Fu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.cbi.2025.111748_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1381612822666151214104826","article-title":"Depression, serotonin and tryptophan","volume":"22","author":"Dell'Osso","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cbi.2025.111748_bib30","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/ctm2.1042","article-title":"The positive regulatory loop of TCF4N\/p65 promotes glioblastoma tumourigenesis and chemosensitivity","volume":"12","author":"Hu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cbi.2025.111748_bib31","article-title":"Elucidating the mechanisms of temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.cbi.2025.111748_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13046-022-02431-0","article-title":"PDIA3P1 promotes temozolomide resistance in glioblastoma by inhibiting C\/EBP\u03b2 degradation to facilitate proneural-to-mesenchymal transition","volume":"41","author":"Gao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111748_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s13046-022-02526-8","article-title":"ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells","volume":"41","author":"Gao","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111748_bib34","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.7150\/thno.82590","article-title":"SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages","volume":"13","author":"Fan","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2025.111748_bib35","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.cbi.2025.111748_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106316","article-title":"Comparative efficacy and safety of therapeutics for elderly glioblastoma patients: a Bayesian network analysis","volume":"182","author":"Zhao","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2025.111748_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116113","article-title":"Daurisoline suppress glioma progression by inhibiting autophagy through PI3K\/AKT\/mTOR pathway and increases TMZ sensitivity","volume":"223","author":"Yin","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2025.111748_bib38","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13046-024-03175-9","article-title":"The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2025.111748_bib39","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.7150\/ijbs.70546","article-title":"HTR1D functions as a key target of HOXA10-AS\/miR-340-3p axis to promote the malignant outcome of pancreatic cancer via PI3K-AKT signaling pathway","volume":"18","author":"Wu","year":"2022","journal-title":"Int. J. Biol. Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725003783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279725003783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:05:32Z","timestamp":1780722332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279725003783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"alternative-id":["S0009279725003783"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111748","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HTR1D regulates the PI3K\/Akt signaling pathway to impact glioblastoma development and resistance to temozolomide","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2025.111748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111748"}}